Skip to content

Depression: all studies

Page 856 of 1,034: studies 8,551 to 8,560 of 10,336, newest first. Back to the depression overview

Research

Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis

January 14, 2019 Simon B. Goldberg, Raymond P. Tucker, Preston A. Greene et al. 38 citations

Despite widespread scientific and popular interest in mindfulness-based interventions, questions regarding the empirical status of these treatments remain. We sought to examine the efficacy of mindfulness-based interventions for clinical populations on disorder-specific symptoms. To address the question of relative efficacy, we coded the strength of the comparison group into five categories: no...

DOI: 10.31231/osf.io/etghn (opens in new tab) Mindfulness Psychological intervention Clinical psychology Meta-analysis +2

The Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) in Real-World Healthcare Services

Mindfulness January 12, 2019 Alice Tickell, Susan Ball, Paul Bernard et al.

Depression is common with a high risk of relapse/recurrence. There is evidence from multiple randomised controlled trials (RCTs) demonstrating the efficacy of mindfulness-based cognitive therapy (MBCT) for the prevention of depressive relapse/recurrence, and it is included in several national clinical guidelines for this purpose. However, little is known about whether MBCT is being delivered...

Ketamine promotes rapid and transient activation of AMPA receptor-mediated synaptic transmission in the dorsal raphe nucleus.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 10, 2019 Nerea Llamosas, Laura Perez-Caballero, Esther Berrocoso et al.

Accumulating evidence indicates that the antidepressant effects of ketamine are, in part, mediated by an increase in the AMPA receptor-mediated neurotransmission in depression related areas, such as the prefrontal cortex (PFC). Therefore, activity in PFC-projecting areas related to major depression, such as the dorsal raphe nucleus (DR), may also be modulated by ketamine. We used whole-cell...

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.

Experimental and Clinical Psychopharmacology January 10, 2019 Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke et al. 42 citations

The prototype 5-HT2A receptor agonist hallucinogens LSD, mescaline, and psilocybin are classified as Schedule 1 drugs of abuse by the U.S. Drug Enforcement Administration. Accumulating clinical evidence has also suggested that acute or repeated "microdosing" with these drugs may have utility for treatment of some mental health disorders, including drug abuse and depression. The goal of the...

Novel Synthetic Mixed Hallucinogen/Stimulants: Definition, Pharmacology, and Clinical Manifestations

January 5, 2019

Intoxication results in a mixture of hallucinogenic and stimulant signs and symptoms, including anxiety, depression, paranoia, hallucinations, agitation, confusion, nausea, abdominal discomfort, tachycardia, hypertension, muscle clonus, and pupillary dilation. Life-threatening medical complications include excited delirium, seizures, hyperthermia, and pulmonary edema. Toxic serotonergic...

Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine

American Journal of Psychiatry January 4, 2019 Satoshi Deyama, Eunyoung Bang, Eric S. Wohleb et al. 100 citations

OBJECTIVE: -methyl-d-aspartate receptor antagonist ketamine produces rapid and sustained antidepressant actions even in patients with treatment-resistant depression. Vascular endothelial growth factor (VEGF) has been implicated in the effects of conventional monoamine-based antidepressants, but the role of VEGF in the rapid antidepressant actions of ketamine remains unclear. The authors...

DOI: 10.1176/appi.ajp.2018.17121368 (opens in new tab) Ketamine Antidepressant Prefrontal cortex Neurotrophic factors +5

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers

Psychopharmacology January 2, 2019 Thomas Anderson, Rotem Petranker, Daniel Rosenbaum et al. 171 citations

RationaleMicrodosing psychedelics-the regular consumption of small amounts of psychedelic substances such as LSD or psilocybin-is a growing trend in popular culture. Recent studies on full-dose psychedelic psychotherapy reveal promising benefits for mental well-being, especially for depression and end-of-life anxiety. While full-dose therapies include perception-distorting properties,...

DOI: 10.1007/s00213-018-5106-2 (opens in new tab) Creativity Mental health Personality Clinical psychology +1

Chronic Early Stress Impairs Default Mode Network Connectivity in Preadolescents and Their Mothers.

Biological psychiatry. Cognitive neuroscience and neuroimaging January 2019 Maor Zeev-Wolf, Jonathan Levy, Abraham Goldstein et al.

Early life stress (ELS) bears long-term negative consequences throughout life. Yet ELS effect is mostly unknown, and no study has followed children to test its impact on the default mode network (DMN) in relation to maternal behavior across childhood. Focusing on brain oscillations, we utilized a unique cohort of war-exposed preadolescent children (11-13 years of age) and their mothers followed...

Effect of Meditation on Social/Emotional Well-Being in a High-Performing High School

Professional School Counseling 2019 Jane E. Bleasdale, Margaret C. Peterson, Sanford Nidich

This study explored the impact of a meditation program on stress, anxiety, and depression in a high-performing high school. Using a randomized controlled design with 52 students, the study took place over 4 months. Students participated in Transcendental Meditation (treatment) or silent reading (active control) twice daily. We observed significant reductions in perceived stress (p = .040),...

The olfactory bulb is a source of high-frequency oscillations (130-180 Hz) associated with a subanesthetic dose of ketamine in rodents.

Neuropsychopharmacology January 2019 Mark Jeremy Hunt, Natalie E Adams, Władysław Średniawa et al.

High-frequency neuronal population oscillations (HFO, 130-180 Hz) are robustly potentiated by subanesthetic doses of ketamine. This frequency band has been recorded in functionally and neuroanatomically diverse cortical and subcortical regions, notably ventral striatal areas. However, the locus of generation remains largely unknown. There is compelling evidence that olfactory regions can drive...